Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study.

RATIONALE A significant proportion of smokers have lung function impairment characterized by a reduced FEV(1) with a preserved FEV(1)/FVC ratio. These smokers are a poorly characterized group due to their systematic exclusion from chronic obstructive pulmonary disease (COPD) studies. OBJECTIVES To characterize the clinical, functional, and radiographic features of Global Initiative for Chronic Obstructive Lung Disease (GOLD)-Unclassified (FEV(1)/FVC ≥ 0.7 and FEV(1) < 80% predicted) and lower limits of normal (LLN)-unclassified (FEV(1)/FVC ≥ LLN and FEV(1) < LLN) subjects compared to smokers with normal lung function and subjects with COPD. METHODS Data from the first 2,500 subjects enrolled in the COPDGene study were analyzed. All subjects had 10 or more pack-years of smoking and were between the ages of 45 and 80 years. Multivariate regression models were constructed to determine the clinical and radiological variables associated with GOLD-Unclassified (GOLD-U) and LLN-Unclassified status. Separate multivariate regressions were performed in the subgroups of subjects with complete radiologic measurement variables available. MEASUREMENTS AND MAIN RESULTS GOLD-U smokers account for 9% of smokers in COPDGene and have increased body mass index (BMI), a disproportionately reduced total lung capacity, and a higher proportion of nonwhite subjects and subjects with diabetes. GOLD-U subjects exhibit increased airway wall thickness compared to smoking control subjects and decreased gas trapping and bronchodilator responsiveness compared to subjects with COPD. When LLN criteria were used to define the "unclassified" group, African American subjects were no longer overrepresented. Both GOLD-U and LLN-Unclassified subjects demonstrated a wide range of lung function impairment, BMI, and percentage of total lung emphysema. CONCLUSIONS Subjects with reduced FEV(1) and a preserved FEV(1)/FVC ratio are a heterogeneous group with significant symptoms and functional limitation who likely have a variety of underlying etiologies beyond increased BMI. Clinical trial registered with www.clinicaltrials.gov (NCT000608764).

[1]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[2]  E. Regan,et al.  Clinical And Radiographic Predictors Of GOLD-Unclassified Subjects In COPDGene , 2011, ATS 2011.

[3]  D. Schroeder,et al.  The nonspecific pulmonary function test: longitudinal follow-up and outcomes. , 2011, Chest.

[4]  Katherine P Andriole,et al.  Lung volumes and emphysema in smokers with interstitial lung abnormalities. , 2011, The New England journal of medicine.

[5]  E. Regan,et al.  Genetic Epidemiology of COPD (COPDGene) Study Design , 2011, COPD.

[6]  W. MacNee,et al.  Airway dimensions in COPD: relationships with clinical variables. , 2010, Respiratory medicine.

[7]  M. Zeegers,et al.  Pulmonary function in diabetes: a metaanalysis. , 2010, Chest.

[8]  O. Melander,et al.  Population-based study of lung function and incidence of heart failure hospitalisations , 2010, Thorax.

[9]  S. Guerra,et al.  Morbidity and mortality associated with the restrictive spirometric pattern: a longitudinal study , 2010, Thorax.

[10]  C. Janson,et al.  How often is diagnosis of COPD confirmed with spirometry? , 2010, Respiratory medicine.

[11]  Fereidoun Abtin,et al.  Reproducibility of lung and lobar volume measurements using computed tomography. , 2010, Academic radiology.

[12]  E. Silverman,et al.  Sex differences in emphysema and airway disease in smokers. , 2009, Chest.

[13]  Raúl San José Estépar,et al.  CT metrics of airway disease and emphysema in severe COPD. , 2009, Chest.

[14]  A. Gulsvik,et al.  Quantitative computed tomography: emphysema and airway wall thickness by sex, age and smoking , 2009, European Respiratory Journal.

[15]  L. Guize,et al.  Lung function impairment and metabolic syndrome: the critical role of abdominal obesity. , 2009, American journal of respiratory and critical care medicine.

[16]  S. Iwano,et al.  3D-CT volumetry of the lung using multidetector row CT: comparison with pulmonary function tests. , 2009, Academic radiology.

[17]  Jie Zheng,et al.  Airway remodeling measured by multidetector CT is increased in severe asthma and correlates with pathology. , 2008, Chest.

[18]  S Muro,et al.  Body mass index in male patients with COPD: correlation with low attenuation areas on CT , 2008, Thorax.

[19]  P. Calverley,et al.  A Unique Spirometric Phenotype in COPD , 2008 .

[20]  S. Verbanck,et al.  Forced vital capacity and forced expiratory volume in six seconds as predictors of reduced total lung capacity , 2008, European Respiratory Journal.

[21]  Russell Mardon,et al.  Spirometry utilization for COPD: how do we measure up? , 2007, Chest.

[22]  Susan Murray,et al.  Sex differences in severe pulmonary emphysema. , 2007, American journal of respiratory and critical care medicine.

[23]  Richard L. Jones,et al.  The effects of body mass index on lung volumes. , 2006, Chest.

[24]  Geoffrey McLennan,et al.  State of the Art. A structural and functional assessment of the lung via multidetector-row computed tomography: phenotyping chronic obstructive pulmonary disease. , 2006, Proceedings of the American Thoracic Society.

[25]  K. Weiss,et al.  Spirometry use in clinical practice following diagnosis of COPD. , 2006, Chest.

[26]  Y Fukuchi,et al.  Increasing COPD awareness , 2006, European Respiratory Journal.

[27]  W. Bailey,et al.  Racial and gender differences in susceptibility to tobacco smoke among patients with chronic obstructive pulmonary disease. , 2004, Respiratory medicine.

[28]  S. Weiss,et al.  Lung function in type 2 diabetes: the Normative Aging Study. , 2005, Respiratory medicine.

[29]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.

[30]  D. Mannino,et al.  Risk factors for prevalence of and mortality related to restriction on spirometry: findings from the First National Health and Nutrition Examination Survey and follow-up. , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[31]  N. Pride,et al.  Postural changes in lung volumes and respiratory resistance in subjects with obesity. , 2005, Journal of applied physiology.

[32]  Yasutaka Nakano,et al.  The prediction of small airway dimensions using computed tomography. , 2005, American journal of respiratory and critical care medicine.

[33]  R. Crapo,et al.  Validity of the American Thoracic Society and other spirometric algorithms using FVC and forced expiratory volume at 6 s for predicting a reduced total lung capacity. , 2004, Chest.

[34]  D. Mannino,et al.  Obstructive and restrictive lung disease and functional limitation: data from the Third National Health and Nutrition Examination , 2003, Journal of internal medicine.

[35]  F. Raschke,et al.  Usefulness of GOLD classification of COPD severity , 2003, Thorax.

[36]  D. Mannino,et al.  Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study , 2003, Thorax.

[37]  P. Nilsson,et al.  Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study , 2003, Journal of internal medicine.

[38]  D. Sin,et al.  Obesity is a risk factor for dyspnea but not for airflow obstruction. , 2002, Archives of internal medicine.

[39]  E. Silverman.  Genetic Epidemiology of COPD. , 2002, Chest.

[40]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.

[41]  C. Salome,et al.  Obesity is a risk for asthma and wheeze but not airway hyperresponsiveness , 2001, Thorax.

[42]  T L Petty,et al.  Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. , 2000, Archives of internal medicine.

[43]  S. Aaron,et al.  How accurate is spirometry at predicting restrictive pulmonary impairment? , 1999, Chest.

[44]  J L Hankinson,et al.  Spirometric reference values from a sample of the general U.S. population. , 1999, American journal of respiratory and critical care medicine.

[45]  N. Pride,et al.  Effects of posture on respiratory mechanics in obesity. , 1995, Journal of applied physiology.

[46]  J. Stocks,et al.  Reference values for residual volume, functional residual capacity and total lung capacity. ATS Workshop on Lung Volume Measurements. Official Statement of The European Respiratory Society. , 1995, The European respiratory journal.

[47]  R. Rogers,et al.  Pulmonary function abnormalities in chronic severe cardiomyopathy preceding cardiac transplantation. , 1992, The American review of respiratory disease.

[48]  P. Batra,et al.  Ventilatory and diffusion abnormalities in potential heart transplant recipients. , 1990, Chest.